Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopausen AMS on Instagram

Cardiovascular risk assessment in women – an update

White paperCardiovascular disease is the leading cause of morbidity and mortality in postmenopausal women. Although it is a disease of aging, vascular disease initiates much earlier in life.

Thus, there is a need to be aware of the potential to prevent the development of the disease from an early age and continue this surveillance throughout life. The menopausal period and early menopause present an ideal opportunity to assess cardiovascular risk and plan accordingly. Generally in this period, women will be seen by primary health-care professionals and non-cardiovascular specialists.

This review addresses female specific risk factors that may contribute to the potential development of cardiovascular disease.

It is important for all health-care professionals dealing with women in midlife and beyond to be cognisant of these risk factors and to initiate female-specific preventative measures or to refer to a cardiovascular specialist.

pdfA White Paper - Cardiovascular risk assessment in women - an update867.2 KB

Note: The IMS grants permission to individuals only to reproduce the copies of the review for their own personal use but requests that organisations contact Ms Lee Tomkins, IMS Executive Director for advice on how to order reprints at This email address is being protected from spambots. You need JavaScript enabled to view it..

Reference

P. Collins, C. M. Webb, T. J. de Villiers, J. C. Stevenson, N. Panay & R. J. Baber (2016) Cardiovascular risk assessment in women – an update, Climacteric, 19:4, 329-336, DOI: 10.1080/13697137.2016.1198574  http://dx.doi.org/10.1080/13697137.2016.1198574

Content updated 28 October 2016

Print Email

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopauseAMS on Instagram